Lingling Shen

机构：Shimadzu (China), Henan Medical University · ORCID：0000-0002-7971-1555

发表论文 34 篇 · 总被引 489 次 · h-index 13

代表论文

• Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial (2019 · Cancer Medicine · 被引 57)
• FPS-ZM1 Alleviates Neuroinflammation in Focal Cerebral Ischemia Rats via Blocking Ligand/RAGE/DIAPH1 Pathway (2020 · ACS Chemical Neuroscience · 被引 35)
• Identification and Validation of IFI44 as Key Biomarker in Lupus Nephritis (2021 · Frontiers in Medicine · 被引 32)
• HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells (2019 · Neural Plasticity · 被引 32)
• A Novel Reference for Bt-Resistance Mechanism in Plutella xylostella Based on Analysis of the Midgut Transcriptomes (2021 · Insects · 被引 17)
• Genome-wide analysis of V-ATPase genes in Plutella xylostella (L.) and the potential role of PxVHA-G1 in resistance to Bacillus thuringiensis Cry1Ac toxin (2021 · International Journal of Biological Macromolecules · 被引 16)